[an error occurred while processing this directive]
BBC News
watch One-Minute World News
Last Updated: Friday, 20 October 2006, 00:17 GMT 01:17 UK
'Back NICE' government is urged
Pills
The Lancet wants a debate on how to finance health
The government needs to show vocal support for the National Institute for Health and Clinical Excellence (NICE), a leading medical journal says.

A Lancet editorial said the NHS drugs watchdog should be backed for being the best way to ensure fairness across the country's health system.

The call follows Alzheimer's groups accusing NICE of "blatant cost cutting" over a decision on drugs.

The government said the body should operate without political interference.

NICE was set up seven years ago to advise ministers in England and Wales on what treatments should be available on the NHS.

The Health Secretary and the Welsh Assembly can instruct NICE to consider whether certain drugs or treatments should be used on the NHS.

'Not a rationing body'

Last week it rejected five appeals against its guidance to restrict the use of four drugs for Alzheimer's disease, prompting condemnation from support groups.

The government's response at the time was to say that it would be "entirely inappropriate" to overrule NICE's decision.

NICE FACTS
NICE was set up by the Labour government in 1999
It has looked at drugs for flu, multiple sclerosis, hip replacements, coronary heart disease and breast and ovarian cancer
Decisions only apply in England and Wales
They can only be implemented by the Health Secretary and the health minister for Wales

The Lancet says NICE's recommendations are necessary to make the best use of limited NHS funds and the government's patient choice agenda ignores the need for rational spending.

The Department of Health said: "It [NICE] is not a rationing body.

"The institute was established to give advice to the NHS where there was uncertainty over the clinical and cost effectiveness of specific drugs and other treatments.

"NICE's remit is to produce robust, workable and evidence based guidance, free from political interference and we support the Institute in this role."

But the Lancet said: "If the government really wants to extend choice within the NHS, as it has pledged, it should launch a debate about the health-financing framework necessary to support this philosophy.

"But its first obligation should be to show vocal support for NICE as the best mechanism to ensure equity in the UK's current health system."


SEE ALSO
Drug watchdog costs too much
22 Jul 04 |  Health
Is anyone listening to NICE?
25 May 04 |  Health
Drugs watchdog comes under fire
16 Sep 03 |  Health
Q&A: What is NICE?
14 Oct 02 |  Health

RELATED INTERNET LINKS
The BBC is not responsible for the content of external internet sites



FEATURES, VIEWS, ANALYSIS
Has China's housing bubble burst?
How the world's oldest clove tree defied an empire
Why Royal Ballet principal Sergei Polunin quit

PRODUCTS & SERVICES

Americas Africa Europe Middle East South Asia Asia Pacific